≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Carcinoma in situ of cervix uteri

DOID EFO Endpoint Browser

CD2_INSITU_CERVIX_UTERI

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

  • not C3_CERVIX_UTERI
292812

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D06
  • Cause of death: ICD-10 — D06
  • Cancer registry: Topography ICD-O-3 — C53
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 2

3 out of 7 registries used, show all original rules.

3860

4. Check minimum number of events

None

3860

5. Include endpoints

3866

6. Filter based on genotype QC (FinnGen only)

3866

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF9
Parent code in ICD-10
D00-D09
Name in latin
Carcinoma in situ vaginae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 3866 3866 -
Unadjusted period prevalence (%) 1.32 1.32 -
Median age at first event (years) 35.40 35.40 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
3487
Matched controls
34871
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
81.7
323.0
2394
909
LDA10
NOMESCO Finland
Curettage of cervix uteri
16.3
323.0
1146
1018
8070/2-C53.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of cervix uteri
+∞
323.0
633
*
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
153.1
323.0
2099
340
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
23.7
323.0
2461
3208
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
9098.7
323.0
2451
7
ULA02
NOMESCO Finland
Kolposcopy
36.9
323.0
2720
3061
N87.1
ICD-10 Finland
Moderate cervical dysplasia
22.2
323.0
875
518
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
24.8
323.0
2117
2041
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
15.7
323.0
2287
3767
D06.0
ICD-10 Finland
Carcinoma in situ: Endocervix
413.3
323.0
339
9
D06.1
ICD-10 Finland
Carcinoma in situ: Exocervix
1212.4
235.0
227
*
8140/2-C53.9
ICD-O-3
Adenocarcinoma in situ, NOS, of cervix uteri
1669.8
160.6
155
*
N87.0
ICD-10 Finland
Mild cervical dysplasia
6.2
141.4
407
722
8077/2-C53.1
ICD-O-3
Squamous intraepithelial neoplasia, high grade of exocervix
1425.5
140.6
136
*
LEB00
NOMESCO Finland
Biopsy of vagina
9.2
105.3
230
267
D06.9
ICD-10 Finland
Carcinoma in situ: Cervix, unspecified
268.4
102.3
104
*
2331A
ICD-9 Finland
Carcinoma in situ of breast and genito-urinary system, Cervix uteri
+∞
94.2
90
*
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
7.7
89.9
217
296
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.0
87.7
1751
11500
23400
ICD-8 Finland
Neoplasm of unspecified nature of uterus, Carcinoma in situ of cervix uteri
+∞
84.7
81
*
ZXC00
NOMESCO Finland
Use of diathermy
14.8
73.9
126
88
8326
FHL
Batch conization
28.2
70.0
96
35
18099
ICD-8 Finland
Malignant neoplasm of cervix uteri
+∞
67.9
65
*
N87.9
ICD-10 Finland
Dysplasia of cervix uteri, unspecified
16.9
65.0
105
64
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.0
51.4
736
4028
X86
ICPC
Abnormal cervix smear
5.4
39.9
124
237
R87.7
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal histological findings
9.4
35.5
74
80
LDB20
NOMESCO Finland
Electrocoagulation or laser therapy of cervix uteri
5.5
35.3
107
199
A63.0
ICD-10 Finland
Anogenital (venereal) warts
2.6
35.3
278
1132
LCA06
NOMESCO Finland
Biopsy of endometrium
1.9
32.4
566
3271
G01AA10
ATC
clindamycin; vaginal
1.7
32.3
786
5057
8140/2-C53.1
ICD-O-3
Adenocarcinoma in situ, NOS, of exocervix
+∞
32.3
31
*
8140/2-C53.0
ICD-O-3
Adenocarcinoma in situ, NOS, of endocervix
+∞
31.3
30
*
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
3.6
31.2
148
428
R87.2
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal level of other drugs, medicaments and biological substances
24.4
29.2
41
17
62191
ICD-8 Finland
Other diseases of cervix, Dysplasia portionis uteri
13.9
28.0
48
35
N89.2
ICD-10 Finland
Severe vaginal dysplasia, not elsewhere classified
31.2
25.9
34
11
8077/2-C52.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vagina, NOS
58.5
25.0
29
5
6221C
ICD-9 Finland
Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI GRAVIS]
26.4
24.8
34
13
LDC00
NOMESCO Finland
Conisation of cervix uteri using knife
19.7
24.7
37
19
LEB30
NOMESCO Finland
Destruction of lesion of vaginal mucosa
7.5
24.1
57
77
8070/3-C53.9
ICD-O-3
Squamous cell carcinoma, NOS, of cervix uteri
16.5
22.7
36
22
18000
ICD-8 Finland
NA
+∞
21.9
21
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.3
21.4
214
982
SPAT1193
SPAT
Pap smear
1.6
20.8
623
4183
N89.0
ICD-10 Finland
Mild vaginal dysplasia
7.0
18.8
46
66
TLC02
NOMESCO Finland
Simple extraction of IUD
2.0
18.8
244
1254
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
2.4
18.3
164
715
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.8
16.7
108
393
8010/2-C53.9
ICD-O-3
Carcinoma in situ, NOS, of cervix uteri
+∞
16.7
16
*
C53.01
ICD-10 Finland
Squamous cell carcinoma of the endocervix
13.4
16.4
28
21
SPAT1263
SPAT
Sampling
1.4
16.4
1412
11621
R87.9
ICD-10 Finland
Abnormal findings in specimens from female genital organs, unspecified abnormal finding
9.8
16.1
32
33
P01AB01
ATC
metronidazole; oral, rectal
1.4
16.1
1391
11442
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
2.4
15.0
128
543
N90.0
ICD-10 Finland
Mild vulvar dysplasia
7.0
14.8
36
52
X23
ICPC
Fear sexually transm dis female
1.7
14.6
337
2103
C53.11
ICD-10 Finland
Squamous cell carcinoma and exocervix
9.7
14.2
28
29
N07BA03
ATC
varenicline; oral
2.0
14.1
177
900
A63.8
ICD-10 Finland
Other specified predominantly sexually transmitted diseases
9.1
13.2
27
30
LCD10
NOMESCO Finland
Vaginal hysterectomy
2.3
12.8
117
517
C53.02
ICD-10 Finland
Adenocarcinoma of the endocervix
11.0
12.5
23
21
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
2.1
11.9
135
659
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.6
11.8
352
2342
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
1.4
11.5
505
3653
N87
ICD-10 Finland
Dysplasia of cervix uteri
11.1
11.5
21
19
C53.12
ICD-10 Finland
Adenocarcinoma of the exocervix
25.1
11.1
15
6
Z20.2
ICD-10 Finland
Contact with and exposure to infections with a predominantly sexual mode of transmission
2.0
11.1
132
658
N76.0
ICD-10 Finland
Acute vaginitis
1.5
11.1
342
2294
WX110
NOMESCO Finland
Local anesthesy
1.3
11.1
2344
21398
X92
ICPC
Chlamydia infection genital female
2.3
10.5
91
396
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
1.8
10.4
167
933
D06BB04
ATC
podophyllotoxin; topical
1.6
10.2
253
1609
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.3
9.9
87
382
N90.2
ICD-10 Finland
Severe vulvar dysplasia, not elsewhere classified
8.1
9.8
21
26
W11
ICPC
Contraception oral
1.4
9.8
556
4212
LBE20
NOMESCO Finland
Laparoscopic bilateral salpingectomy
2.3
9.7
88
390
X85
ICPC
Cervical disease NOS
13.4
9.7
16
12
SPAT1301
SPAT
No procedures
1.3
9.7
876
7127
8077/2-C53.0
ICD-O-3
Squamous intraepithelial neoplasia, high grade of endocervix
100.3
9.4
10
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
9.2
275
1828
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
9.0
1322
11425
N93.0
ICD-10 Finland
Postcoital and contact bleeding
2.9
8.9
51
175
SPAT1312
SPAT
General health counselling
1.3
8.8
1047
8809
N89.1
ICD-10 Finland
Moderate vaginal dysplasia
6.6
8.6
21
32
LCD31
NOMESCO Finland
Radical laparoscopic hysterectomy
11.6
8.6
15
13
SPAT1308
SPAT
Sexual health counselling
1.3
8.3
762
6197
D06BB10
ATC
imiquimod; topical
1.8
8.2
145
838
4044
NOMESCO Finland
NA
11.7
8.1
14
12
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
8.0
2446
22780
D82
ICPC
Teeth/gum disease
1.2
7.3
1181
10244
T74.1
ICD-10 Finland
Physical abuse
2.1
7.3
75
357
T810, N872
ICD-10 Finland
NA
+∞
7.3
7
*
D06.7
ICD-10 Finland
Carcinoma in situ: Other parts of cervix
+∞
7.3
7
*
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
2.1
7.3
81
396
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
4.5
7.1
23
51
6221B
ICD-9 Finland
Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI MODERATA]
7.5
6.9
15
20
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
6.9
1732
15691
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.2
6.8
981
8391
XX3DW
NOMESCO Finland
Time consuming IT work
1.6
6.7
187
1225
N06AX11
ATC
mirtazapine; oral
1.2
6.7
881
7461
R87.8
ICD-10 Finland
Abnormal findings in specimens from female genital organs, other abnormal findings
4.3
6.5
22
51
SPAT1283
SPAT
Restricted health certificate
1.2
6.5
840
7094
LDB00
NOMESCO Finland
Excision of lesion of cervix uteri
2.5
6.5
49
200
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.5
6.5
248
1745
SPAT1238
SPAT
Brief therapy
1.9
6.4
89
477
LCH11
NOMESCO Finland
Pharmacologic abortion
1.5
6.4
244
1718
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
5.9
6.3
16
27
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.2
6.2
774
6514

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3025130) Human papilloma virus identified in Specimen
934
884
13.61
307.65
2.6
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
1234
2164
7.91
307.65
2.6
1.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
470
223
23.85
307.65
2.6
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
2521
10899
4.77
307.65
2.8
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
2478
13664
3.27
269.30
3.1
1.9
—
—
—
0
0
(4035726)
554
2107
2.90
103.70
1.4
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
1276
8415
1.77
55.95
2.3
2.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
1386
9419
1.73
54.30
2.4
2.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
705
4864
1.55
22.43
1.8
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
873
6376
1.48
21.00
2.0
1.8
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
41
79
5.23
20.30
1.8
1.9
ug/l
1.7
2.1
0.40
25
38
(3002256) Pathology report gross observation
551
4094
1.40
11.39
1.3
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
559
4179
1.39
11.13
2.2
2.2
u/l
4996.3
6689.2
0.67
219
1791
(3029937) Albumin [Presence] in Urine by Test strip
1077
8902
1.29
10.80
3.8
3.5
estimate
0.0
0.0
0.10
456
3447
(40761536) Microorganisms panel - Urine sediment
433
3174
1.41
9.62
3.5
3.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1500
13098
1.24
9.04
3.7
3.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
1452
12727
1.23
8.22
2.1
2.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
337
2442
1.42
7.98
1.7
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1877
16931
1.21
7.82
3.6
3.3
estimate
0.0
0.0
2.27
449
3442
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1832
16512
1.21
7.62
3.9
3.9
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1861
16818
1.21
7.47
4.8
4.5
estimate
0.0
0.0
1.08
461
3484
(3035350) Ketones [Presence] in Urine by Test strip
1847
16730
1.20
7.09
3.5
3.3
estimate
0.0
0.0
1.15
442
3386
(3003338) MCHC [Mass/volume]
2838
29850
0.81
7.00
13.3
13.0
g/l
332.4
331.8
2.99
2816
29608
(3041096) Erythrocytes [Presence] in Urine by Automated
1127
9789
1.21
6.65
3.3
2.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
233
1634
1.45
6.63
4.3
2.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2507
23500
1.19
6.07
3.8
3.7
mm/h
9.6
9.8
0.44
2322
22079
(3023103) Potassium [Moles/volume] in Serum or Plasma
3259
31375
1.25
5.74
10.4
10.0
mmol/l
3.9
3.9
0.74
3127
30382
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
370
2893
1.31
5.41
4.4
4.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
3247
31298
1.23
5.34
10.3
9.9
mmol/l
139.5
139.5
0.25
3125
30398
(3037467) Urinalysis macro (dipstick) panel - Urine
2484
23387
1.17
5.27
4.2
4.0
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
327
2536
1.32
5.08
2.3
2.6
u/ml
32.6
39.4
0.57
314
2457
(40760892) CBC W Ordered Manual Differential panel - Blood
939
8191
1.19
5.08
4.2
3.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
288
2208
1.33
4.86
3.9
3.8
%
1.2
0.6
0.43
61
388
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1374
12412
1.17
4.83
5.8
5.2
mmol/l
1.2
1.2
0.45
1126
10466
(3024561) Albumin [Mass/volume] in Serum or Plasma
1235
11067
1.17
4.81
4.5
4.0
g/l
36.6
36.7
0.10
1156
10282
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
13
33
3.95
4.71
1.6
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3403
33058
1.25
4.65
10.9
10.3
mg/l
19.5
18.5
1.11
2646
25430
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
269
2059
1.33
4.61
3.2
2.9
mmol/l
1.2
1.2
0.28
228
1758
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
995
8816
1.17
4.40
2.5
2.3
u/l
51.6
56.3
3.59
911
8180
(3010421) pH of Blood
92
581
1.60
4.38
2.8
2.8
ph
7.4
7.4
0.88
73
474
(3025159) Blasts/100 leukocytes in Blood
284
2207
1.31
4.38
4.1
4.1
%
0.0
0.4
0.84
63
410
(40761511) CBC panel - Blood by Automated count
3587
35100
1.30
4.37
10.6
9.7
—
—
—
0
0
(3013512) EKG study
742
6418
1.19
4.35
2.9
2.8
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
144
1006
1.45
4.29
3.1
2.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
976
8653
1.17
4.26
5.8
5.6
inr
1.1
1.1
1.04
360
2935
(3021440) Promyelocytes/100 leukocytes in Blood
292
2291
1.30
4.20
4.2
4.1
%
0.1
0.2
0.78
74
479
(3031040) Bacteria [#/volume] in Urine by Automated count
2411
22824
1.15
4.19
4.1
4.0
e6/l
1983.3
1614.1
0.10
19
247
(40767503) Oxygen content in Capillary blood by calculation
70
419
1.68
4.13
2.3
2.2
%
17.3
16.7
0.61
39
195
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
970
8617
1.17
4.11
2.6
2.7
ng/l
35.7
33.3
0.07
414
3737
(3026008) Bacteria identified in Urine by Culture
1078
9666
1.16
4.04
2.6
2.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
312
2494
1.27
3.90
2.5
2.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
299
2388
1.27
3.77
4.2
4.0
%
0.8
0.9
0.13
76
514
(3021589) Normoblasts [#/volume] in Blood
1543
14272
1.14
3.59
8.5
7.8
e9/l
0.0
0.0
2.41
1334
11735
(3044640) Blood type and Crossmatch panel - Blood
1148
10423
1.14
3.54
1.9
1.9
—
—
—
0
0
(3012501) Base excess in Blood by calculation
75
479
1.58
3.48
3.0
2.7
mmol/l
2.1
2.4
0.37
38
290
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2337
22215
1.13
3.44
6.9
6.4
u/l
70.8
71.7
0.49
2177
20940
(1761482) Bacteria [#/volume] in Urine by Culture
78
505
1.56
3.42
4.3
3.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1210
11069
1.14
3.28
5.0
4.6
mmol/l
1.2
1.2
0.49
1076
10066
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1528
14188
1.13
3.25
5.4
5.0
umol/l
9.0
9.7
3.99
1437
13325
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
110
774
1.43
3.24
1.3
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
151
1126
1.35
3.17
3.7
4.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
653
5737
1.17
3.14
1.7
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
226
1793
1.28
3.06
2.7
2.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1340
12383
1.13
3.04
1.8
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1185
10875
1.13
3.01
1.7
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2415
23093
1.12
3.00
2.8
2.7
u/l
36.2
32.1
1.50
2291
22029
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
102
720
1.43
2.98
1.3
1.3
u/ml
167.8
109.3
0.75
25
159
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
54
332
1.64
2.97
1.1
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
415
3526
1.20
2.97
1.5
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3487
34191
1.20
2.94
8.8
8.3
u/l
23.3
23.4
0.07
3362
33203
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
494
4267
1.18
2.93
1.6
1.6
%
1.4
1.3
2.76
417
3857
(3016879) Cocaine [Presence] in Urine
263
2138
1.25
2.91
2.6
2.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
38
216
1.77
2.79
1.7
1.6
promille
1.3
1.3
0.06
26
169
(3012932) Hazelnut IgE Ab [Units/volume] in Serum
5
6
8.34
2.75
1.0
1.0
u/ml
0.9
6.6
—
5
6
(1616796) Gas panel - Central venous blood
69
459
1.51
2.75
2.9
2.7
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
3757
37180
1.37
2.73
16.2
15.6
e9/l
6.9
6.8
1.95
3682
36399
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
358
3026
1.20
2.72
2.7
3.4
%
32.8
33.1
0.21
273
2237
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
258
2111
1.24
2.71
2.1
2.1
g/l
0.2
0.2
0.45
237
1988
(3013826) Glucose [Moles/volume] in Serum or Plasma
1744
16435
1.11
2.71
4.0
3.8
mmol/l
6.2
6.3
0.31
1551
14603
(3026361) Erythrocytes [#/volume] in Blood
3756
37177
1.36
2.64
16.2
15.5
e12/l
4.4
4.4
4.99
3680
36427
(3000963) Hemoglobin [Mass/volume] in Blood
3757
37194
1.36
2.58
16.2
15.6
g/l
132.7
132.5
0.74
3716
36842
(3035941) MCH [Entitic mass]
3755
37172
1.35
2.57
16.1
15.5
pg
30.2
30.0
19.56
3715
36825
(3000764) Benzodiazepines [Presence] in Urine
280
2327
1.22
2.55
2.5
2.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
3755
37174
1.35
2.55
16.1
15.5
fl
90.7
90.1
17.62
3714
36828
(3027008) Opiates [Presence] in Urine
281
2339
1.22
2.52
2.5
1.9
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
50
317
1.58
2.49
2.7
2.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
3752
37147
1.34
2.48
16.2
15.6
e9/l
268.0
268.4
0.18
3686
36440
(3028300) Cannabinoids [Presence] in Urine
281
2346
1.21
2.46
2.5
2.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
224
2729
0.81
2.45
2.3
2.2
u/l
37.2
36.5
0.04
193
2312
(3023511) Choriogonadotropin [Units/volume] in Urine
265
2202
1.22
2.43
1.4
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
215
1749
1.24
2.41
1.6
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
473
4141
1.16
2.40
1.7
1.7
nmol/l
1245.6
1197.3
0.58
366
3205
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2907
28234
1.12
2.40
4.3
4.5
pmol/l
14.4
14.3
1.88
2683
26545
(3019150) Specific gravity of Urine by Refractometry
782
7088
1.13
2.38
3.7
3.5
kg/l
1.0
1.0
0.82
110
1097
(3012494) Peanut IgE Ab [Units/volume] in Serum
28
153
1.84
2.38
1.1
1.1
u/ml
3.0
4.5
0.19
16
80
(3007930) Methemoglobin/Hemoglobin.total in Blood
99
728
1.37
2.36
5.0
4.9
%
0.9
0.9
0.58
94
679
(4268621)
26
462
0.56
2.33
2.1
2.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
184
1480
1.26
2.30
1.3
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
98
724
1.36
2.28
5.0
4.8
%
1.7
1.7
0.04
92
676
(3004789) Transferrin [Mass/volume] in Serum or Plasma
431
3763
1.16
2.27
2.4
2.2
g/l
2.4
2.5
0.53
383
3479
(3025941) Bacteria identified in Stool by Culture
267
2239
1.21
2.25
1.3
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
18
3.89
2.25
10.6
10.6
mmol/l
5.5
5.6
—
7
18
(3041806) Other cells [#/volume] in Blood by Manual count
15
313
0.48
2.24
1.2
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
418
3650
1.16
2.20
1.7
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1069
9905
1.11
2.20
5.7
5.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
13
54
2.41
2.19
3.6
4.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
434
4931
0.86
2.16
1.2
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
591
5297
1.14
2.16
2.9
2.4
mosm/kgh2o
519.6
524.7
0.21
502
4480
(3020891) Body temperature
96
715
1.35
2.14
3.3
4.5
—
—
—
0
0
(3019225) pH of Specimen
278
2354
1.19
2.13
2.7
3.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
33
197
1.68
2.11
2.3
2.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
43
656
0.65
2.11
1.2
1.2
u/ml
2.5
4.2
1.52
21
270
(3016502) Oxygen saturation in Arterial blood
214
1770
1.22
2.09
6.2
6.9
%
95.1
96.3
1.21
203
1700
(3038515) Glucose [Moles/volume] in Venous blood
53
356
1.50
2.09
2.6
2.5
mmol/l
6.7
7.2
0.69
53
347
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3230
31631
1.13
2.09
4.9
5.1
mu/l
1.7
2.0
1.77
3002
30018
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
843
7734
1.12
2.08
1.8
1.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
990
9161
1.11
2.08
3.0
2.9
mmol/l
2.3
2.3
0.14
895
8211
(40761535) Cells panel - Urine sediment
242
2031
1.20
2.05
3.4
3.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
421
3703
1.15
2.03
3.0
2.9
mmol/l
0.8
0.8
1.05
390
3454
(3021447) Carbon dioxide [Partial pressure] in Venous blood
205
1697
1.22
2.00
4.8
3.3
kpa
5.8
5.8
0.12
198
1635
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
169
2070
0.81
1.99
2.2
2.2
ml/min/173m2
73.0
77.4
0.82
67
779
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
57
393
1.46
1.99
1.4
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
84
621
1.36
1.99
1.4
1.4
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
16
77
2.08
1.96
1.1
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
624
5650
1.12
1.94
1.6
1.6
pmol/l
93834733.8
32037275.8
0.70
519
4885
(3004809) Band form neutrophils/100 leukocytes in Blood
47
314
1.50
1.93
3.1
2.4
%
1.0
1.3
0.35
34
249
(3040151) Glucose [Moles/volume] in Capillary blood
39
250
1.57
1.92
3.6
6.3
mmol/l
6.3
6.8
0.40
32
203
(3047352) Trisomy 18 risk [Likelihood] in Fetus
242
2848
0.84
1.90
1.4
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
229
1928
1.20
1.90
3.6
3.5
ug/l
11.3
31.9
0.54
181
1398
(3039000) Anion gap in Blood
58
407
1.43
1.87
5.1
6.9
mmol/l
11.3
11.1
0.19
53
364
(3024522) Salmonella sp identified in Specimen by Organism specific culture
52
358
1.46
1.85
1.5
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
137
1096
1.26
1.85
1.8
1.6
iu/ml
0.0
0.4
1.23
28
196
(3018572) Chloride [Moles/volume] in Blood
58
408
1.43
1.85
5.1
6.9
mmol/l
105.6
105.6
0.00
53
365
(3025468) Yersinia sp identified in Specimen by Organism specific culture
51
350
1.46
1.85
1.5
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
51
350
1.46
1.85
1.5
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
700
6399
1.11
1.84
1.3
1.3
u/ml
11.2
9.1
0.41
293
2717
(3005719) IgG [Mass/volume] in Serum or Plasma
269
2304
1.18
1.84
2.4
2.5
g/l
10.3
10.5
0.39
244
2125
(3008152) Bicarbonate [Moles/volume] in Arterial blood
140
1124
1.25
1.84
6.2
6.6
mmol/l
24.4
24.3
0.07
129
1043
(3005988) Vibrio sp identified in Specimen by Organism specific culture
51
351
1.46
1.82
1.5
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
733
6722
1.11
1.82
1.2
1.3
iu/ml
66.0
23.4
0.54
249
2083
(44813793)
48
327
1.47
1.81
1.1
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
55
385
1.43
1.81
2.5
2.4
mmol/l
1.4
1.4
0.03
55
374
(1002224) Polysomnography panel
118
1481
0.79
1.76
1.1
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
208
1750
1.20
1.75
1.6
1.8
g/l
1.2
1.4
1.54
190
1621
(3024354) Oxygen [Partial pressure] in Venous blood
166
1366
1.22
1.75
4.4
2.8
kpa
4.3
4.6
1.40
159
1310
(3023368) Bacteria identified in Blood by Culture
625
5694
1.12
1.75
3.6
3.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
65
472
1.38
1.75
2.5
2.7
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
241
2057
1.18
1.73
6.2
6.4
kpa
12.9
13.5
0.80
229
1962
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
241
2057
1.18
1.73
6.2
6.4
kpa
5.0
5.0
0.05
228
1964
(3002032) Base excess in Venous blood by calculation
200
1679
1.20
1.73
4.9
3.3
mmol/l
1.8
1.8
0.03
154
1352
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
52
364
1.43
1.72
1.5
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
269
2319
1.17
1.72
2.5
2.0
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
1661
15861
1.08
1.69
5.6
5.6
e9/l
0.0
0.0
0.40
1503
13974
(3005033) Fetal Nuchal fold Thickness US
244
2835
0.85
1.67
1.4
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
51
358
1.43
1.67
1.5
1.4
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
6
19
3.16
1.66
1.2
1.1
mmol/l
8.2
8.2
—
6
19
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3034
29706
1.10
1.66
3.4
3.5
mmol/l
5.6
5.6
0.66
2805
27811
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
104
819
1.28
1.63
4.5
2.6
%
0.6
0.7
0.64
95
783
(3028679) Herpes simplex virus Ab [Presence] in Serum
43
297
1.45
1.55
1.2
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
253
2909
0.86
1.54
1.5
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
1002
9405
1.09
1.53
1.7
1.7
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
15
3.34
1.52
1.0
1.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
1650
15804
1.08
1.50
5.6
5.5
e9/l
0.5
0.5
0.26
1500
13961
(40758558) Short blood count panel - Blood
712
7680
0.91
1.49
6.0
6.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
30
194
1.55
1.48
2.3
2.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
9
37
2.44
1.47
1.0
1.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
191
1625
1.18
1.47
1.2
1.3
u/ml
0.3
1.1
2.01
19
128
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
134
1617
0.82
1.44
1.1
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
50
361
1.39
1.44
3.5
2.5
umol/l
31.8
33.4
0.25
44
316
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
5
16
3.13
1.44
1.0
1.4
%
17.6
10.8
—
5
8
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
16
3.13
1.44
1.0
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
1968
18995
1.07
1.43
2.7
2.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
795
7411
1.09
1.42
3.7
3.4
ph
7.4
7.4
0.19
185
1425
(3023323) Follitropin [Units/volume] in Serum or Plasma
403
3629
1.12
1.42
1.3
1.3
iu/l
23.0
23.5
0.13
367
3138
(3002173) Hemoglobin [Mass/volume] in Arterial blood
197
1687
1.18
1.41
7.1
7.1
g/l
119.7
120.6
0.28
189
1626
(4010399)
213
1837
1.17
1.40
1.3
1.4
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
25
157
1.60
1.40
1.1
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1714
16473
1.07
1.39
5.7
5.8
e9/l
0.2
0.2
0.16
1581
14776
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
14
74
1.90
1.39
2.4
2.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3003
29462
1.09
1.37
9.1
8.6
ml/min/173m2
91.9
92.3
0.59
2439
23868
(3001019) Free T4 and TSH panel - Serum or Plasma
293
3302
0.88
1.36
1.5
1.7
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
50
676
0.74
1.36
1.2
1.2
u/ml
3.3
2.9
0.08
23
224
(3007916) DNA double strand Ab [Titer] in Serum
9
42
2.15
1.33
1.0
1.5
—
93.6
—
0
6
(3016650) Hepatitis A virus Ab [Presence] in Serum
71
550
1.30
1.32
1.2
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
409
3704
1.12
1.32
1.8
1.8
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
100
809
1.24
1.31
1.3
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
236
2066
1.15
1.30
6.2
6.4
mmol/l
0.7
0.9
0.28
174
1555
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
34
2.36
1.29
1.8
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
94
757
1.25
1.28
1.3
1.2
u/ml
321.2
261.6
1.12
70
511
(3022948) Iron [Moles/volume] in Serum or Plasma
460
4201
1.11
1.27
2.4
2.2
umol/l
14.8
14.2
0.82
412
3891
(3034426) Prothrombin time (PT)
6
134
0.45
1.27
1.5
1.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
121
1003
1.21
1.27
2.1
2.3
g/l
3.6
3.6
0.12
110
940
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
34
235
1.45
1.27
1.5
1.5
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
9
44
2.05
1.26
1.1
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
95
768
1.24
1.26
1.9
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
567
5236
1.10
1.25
2.5
2.4
ug/g
109.1
93.8
0.47
436
4088
(3006184) Hemoglobin [Mass/volume] in Capillary blood
64
493
1.30
1.25
2.2
2.1
g/l
134.7
130.6
0.90
52
370
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
45
2.00
1.23
1.1
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
67
521
1.29
1.23
2.8
2.2
—
—
—
0
0
(3006598) pH of Arterial cord blood
5
19
2.63
1.21
1.2
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
561
5188
1.10
1.21
1.4
1.4
titre
600.3
595.8
0.02
116
1060
(3016038) Potassium [Moles/volume] in Urine
19
116
1.64
1.21
1.3
1.2
mmol/l
36.4
33.7
0.21
19
107
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
127
1064
1.20
1.20
1.8
2.0
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
268
2381
1.13
1.20
4.1
4.0
u/l
226.1
233.2
0.44
251
2256
(3023520) Reticulocytes [#/volume] in Blood
171
1471
1.17
1.20
2.0
2.5
e9/l
67.5
73.3
1.40
133
1073
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
115
955
1.21
1.20
1.8
1.9
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
17
101
1.69
1.19
1.3
1.5
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
266
2364
1.13
1.19
7.1
6.0
mmol/l
104.6
104.8
0.36
257
2313
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
36
256
1.41
1.17
1.1
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
763
7162
1.08
1.16
1.9
1.9
u/l
170.1
139.5
0.47
720
6779
(3013650) Neutrophils [#/volume] in Blood by Automated count
1872
18122
1.06
1.16
8.3
8.1
e9/l
4.0
4.0
0.50
1698
16002
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
32
223
1.44
1.16
1.3
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
152
1300
1.18
1.15
4.2
2.9
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
20
126
1.59
1.14
1.5
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
154
0.52
1.13
3.4
4.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
26
175
1.49
1.12
1.0
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
41
301
1.37
1.12
1.1
1.1
ratio
1.0
1.0
0.00
12
116
(3026389) Candida sp identified in Specimen by Organism specific culture
71
564
1.26
1.12
1.4
1.3
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
27
184
1.47
1.10
1.0
1.1
%
101.2
94.9
0.58
12
74
(3006504) Eosinophils/100 leukocytes in Blood
1541
14847
1.06
1.10
5.6
5.5
%
2.6
2.7
0.73
1443
13855
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
26
176
1.48
1.10
1.0
1.1
%
99.6
98.2
0.07
11
72
(3030467) Casts [#/volume] in Urine by Automated count
794
7486
1.08
1.08
2.7
2.7
e6/l
0.4
0.3
0.67
599
5487
(3047007) Chlamydophila sp Ab [Presence] in Serum
76
612
1.25
1.08
1.3
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
22
145
1.52
1.05
2.1
1.9
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
33
2.12
1.05
1.6
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
670
7135
0.93
1.05
1.6
1.6
mmol/l
1.4
1.3
0.64
550
6231
(3010144) Erythrocytes [#/volume] in Synovial fluid
28
195
1.44
1.04
1.3
1.5
e6/l
69104.9
94544.8
0.12
14
133
(3009343) pH of Capillary blood
132
1128
1.18
1.04
3.3
2.8
ph
7.4
7.4
0.88
31
154
(3019069) Monocytes/100 leukocytes in Blood
1547
14930
1.06
1.03
5.8
5.8
%
7.8
7.9
0.60
1461
14061
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
47
609
0.77
1.01
1.1
1.1
%
113.8
118.5
0.34
40
550
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
133
1141
1.17
1.01
3.3
2.8
kpa
5.3
5.1
1.45
126
1071
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
22
147
1.50
1.00
2.7
2.7
umol/l
156.5
179.8
0.18
16
81
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
50
639
0.78
0.98
1.1
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
5
23
2.18
0.98
1.2
2.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
82
675
1.22
0.98
4.6
5.2
mmol/l
1.2
1.2
0.09
75
590
(3000285) Sodium [Moles/volume] in Blood
0
29
0.00
0.97
0.0
1.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2706
26567
1.06
0.97
4.0
4.2
mmol/mol
36.8
37.4
3.98
2515
25082
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
20
132
1.52
0.97
1.4
1.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
369
3390
1.10
0.95
2.6
2.3
%
24.8
23.5
0.87
306
2916
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
15
234
0.64
0.94
1.3
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
39
294
1.33
0.94
1.2
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
26
183
1.42
0.93
1.2
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
12
70
1.72
0.92
1.3
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
12
70
1.72
0.92
1.3
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
12
70
1.72
0.92
1.3
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
12
70
1.72
0.92
1.3
1.1
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
6
28
2.14
0.91
1.0
1.0
—
6.1
—
0
11
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
39
296
1.32
0.90
1.2
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
819
7784
1.07
0.90
2.1
2.1
mg/l
2.7
2.7
0.08
702
6704
(3022096) Basophils/100 leukocytes in Blood
1481
14323
1.06
0.90
5.7
5.6
%
0.6
0.7
1.27
1388
13369
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
37
279
1.33
0.90
1.7
1.7
%
53.6
50.3
0.23
25
166
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
29
2.07
0.89
10.5
5.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
345
3173
1.10
0.88
2.7
2.3
umol/l
5.9
6.0
0.06
280
2643
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
31
416
0.74
0.88
1.1
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
30
2.00
0.87
3.3
5.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
126
1093
1.16
0.86
3.4
2.8
mmol/l
2.1
1.4
1.11
97
790
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
81
677
1.20
0.86
1.7
1.5
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
8
44
1.82
0.85
1.1
1.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
12
72
1.67
0.85
1.1
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
93
790
1.18
0.83
1.2
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
741
7042
1.06
0.82
3.4
3.2
mmol/l
7.3
7.4
0.28
632
6098
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
73
607
1.21
0.82
1.2
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
64
526
1.22
0.81
1.3
1.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
95
811
1.18
0.81
1.3
1.3
titre
188.0
126.7
—
10
73
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
42
329
1.28
0.80
1.2
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
27
198
1.37
0.80
3.0
2.1
%
60.3
54.8
0.46
17
129
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.0
—
0.7
—
0
20
(3003157) Bacteria [#/volume] in Mother's milk
0
25
0.00
0.79
0.0
7.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
40
508
0.79
0.79
1.7
1.5
g/l
0.5
0.6
0.52
27
384
(3017569) Oxygen content in Arterial blood
11
66
1.67
0.78
4.6
2.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
13
199
0.65
0.78
1.0
1.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
1690
16450
1.05
0.77
5.6
5.5
e9/l
2.0
2.0
0.05
1562
14836
(3009871) Measles virus Ab [Titer] in Serum
7
123
0.57
0.77
1.3
1.8
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
172
1538
1.12
0.77
8.9
6.7
mmol/l
8.9
7.4
1.91
161
1473
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
254
2322
1.10
0.76
1.6
1.6
—
—
—
0
0
(4024509)
20
280
0.71
0.76
1.3
1.5
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
16
107
1.50
0.76
1.4
2.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2982
29440
1.06
0.75
3.0
3.1
mmol/l
1.2
1.2
1.55
2792
27856
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
110
958
1.15
0.74
8.3
8.2
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
25
184
1.36
0.73
1.0
1.1
u/ml
15.5
6.7
—
5
34
(3050129) First trimester maternal screen panel - Serum or Plasma
403
4307
0.93
0.73
1.4
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
78
662
1.18
0.73
2.7
2.7
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
73
616
1.19
0.73
2.0
1.9
ug/l
2.2
1.9
0.10
62
540
(3036071) Salmonella sp Ab [Titer] in Serum
8
136
0.59
0.72
1.4
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
472
4441
1.07
0.72
2.6
2.4
mmol/l
2.4
2.4
0.00
410
3835
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
13
84
1.55
0.71
1.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
33
255
1.30
0.71
1.0
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
394
3686
1.08
0.71
1.5
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
855
8200
1.05
0.71
2.9
2.7
e6/l
53.4
84.3
0.56
642
6073
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
25
186
1.35
0.70
1.2
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
34
265
1.29
0.69
1.2
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
49
401
1.22
0.68
1.0
1.1
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
18
250
0.72
0.68
12.7
12.6
nmol/l
996.4
858.8
0.69
18
241
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
47
383
1.23
0.67
1.4
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
51
420
1.22
0.67
3.0
3.5
mg/l
54.0
43.7
0.22
36
345
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
51
420
1.22
0.67
3.0
3.5
mg/l
30.8
38.6
0.38
36
345
(3008898) HLA-B27 [Presence]
206
1881
1.10
0.66
1.1
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
24
317
0.76
0.66
1.1
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
12
179
0.67
0.66
1.3
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
80
689
1.16
0.65
1.3
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
10
62
1.61
0.65
2.5
4.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
786
7542
1.05
0.64
2.6
2.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
1091
10554
1.05
0.64
3.3
3.2
e6/l
72.6
77.3
0.11
721
6740
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
29
1.73
0.64
1.0
1.1
umol/24h
1.6
1.4
—
5
29
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
33
415
0.79
0.63
2.2
2.8
ug/min
221.4
94.5
0.26
22
276
(3000034) Microalbumin [Mass/volume] in Urine
23
172
1.34
0.63
2.5
3.0
mg/l
12.8
74.9
1.04
13
117
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
8
131
0.61
0.63
1.1
1.3
—
971.4
—
0
7
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
124
1105
1.13
0.63
1.3
1.4
u/l
18.6
21.1
0.44
93
937
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
95
832
1.15
0.62
1.6
1.6
titre
225.0
294.6
—
5
37
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
66
562
1.18
0.62
1.2
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
19
257
0.74
0.62
16.4
17.9
nmol/l
1656.4
5216.1
0.47
19
248
(1761868) Lipid panel - Serum or Plasma
1319
12824
1.04
0.62
2.2
2.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
102
0.59
0.62
1.0
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
234
2159
1.09
0.61
2.2
2.5
%
1.6
1.7
1.00
204
1904
(3024891) Influenza virus A+B Ag [Presence] in Specimen
90
1027
0.87
0.61
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
132
1184
1.12
0.61
1.3
1.4
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
20
0.00
0.60
0.0
2.0
—
3.2
—
0
8
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.1
—
20.9
—
0
21
(3005322) IgE [Units/volume] in Serum or Plasma
289
2694
1.08
0.60
1.2
1.3
u/ml
240.5
168.8
0.53
262
2498
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
554
5811
0.95
0.60
1.9
2.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
603
5760
1.06
0.59
2.5
2.3
e6/l
9.8
8.9
0.33
516
4980
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
17
232
0.73
0.59
1.4
1.4
umol/l
11.9
9.7
0.52
17
217
(3003577) Lead [Moles/volume] in Blood
0
22
0.00
0.59
0.0
1.2
—
0.1
—
0
8
(4306422)
54
639
0.84
0.59
1.3
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
52
436
1.20
0.59
2.3
2.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
11
72
1.53
0.59
1.1
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
100
884
1.13
0.59
1.3
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
107
1202
0.89
0.58
2.4
2.1
iu/l
103.0
4.1
0.50
55
488
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
256
2378
1.08
0.58
1.6
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
27
210
1.29
0.58
1.6
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
8
54
1.48
0.57
1.1
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
8
54
1.48
0.57
2.5
2.9
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
30
238
1.26
0.56
1.4
2.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
18
241
0.75
0.56
1.2
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1072
10398
1.04
0.56
1.7
1.7
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
5
88
0.57
0.56
2.6
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
3175
32023
0.95
0.56
11.1
11.1
%
39.3
39.4
0.34
2488
26164
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
20
150
1.34
0.55
2.0
1.3
—
—
—
0
0
(4281824)
46
384
1.20
0.55
1.0
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2941
29102
1.04
0.55
12.7
12.4
%
13.4
13.5
1.81
2881
28549
(3045716) Anion gap in Serum or Plasma
13
90
1.45
0.55
10.2
1.8
mmol/l
10.3
9.3
—
7
71
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
98
870
1.13
0.55
1.8
2.0
g/l
1.4
1.4
0.34
83
760
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
18
133
1.36
0.55
2.2
1.9
ug/l
1.5
1.1
0.26
18
124
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
61
1.48
0.53
1.1
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2846
28765
0.96
0.53
3.9
3.9
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
39
1.54
0.53
1.2
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
71
619
1.15
0.52
4.3
3.1
u/ml
103.1
370.5
0.61
59
526
(3030981) Hyaline casts [#/volume] in Urine by Automated count
134
1216
1.11
0.52
3.4
2.4
e6/l
0.3
0.3
0.08
129
1155
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
127
1150
1.11
0.52
1.5
1.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
98
0.61
0.52
1.0
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
258
2414
1.07
0.51
2.3
2.2
e9/l
4.2
4.1
0.18
204
2040
(3035637) Corticotropin [Mass/volume] in Plasma
32
391
0.82
0.51
1.2
1.7
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
26
206
1.26
0.50
1.6
1.6
%
36.0
41.7
0.35
16
117
(3004588) Protein electrophoresis panel - Serum or Plasma
130
1181
1.10
0.50
1.9
2.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
41
1.46
0.50
1.0
1.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
33
270
1.22
0.49
1.2
1.3
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
10
67
1.49
0.49
1.4
1.8
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
86
764
1.13
0.49
2.0
2.2
%
12.8
13.1
2.41
86
757
(40760888) Immunoglobulin light chains.free panel - Serum
38
316
1.20
0.49
3.4
3.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
28
225
1.25
0.49
1.2
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
107
0.65
0.48
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
135
1477
0.91
0.48
1.6
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
33
399
0.83
0.48
9.4
2.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
451
4305
1.05
0.48
2.4
2.3
e6/l
1.4
1.2
0.42
264
2291
(3002030) Lymphocytes/100 leukocytes in Blood
1591
15594
1.03
0.48
5.7
5.5
%
29.4
29.7
0.71
1490
14639
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
25
199
1.26
0.47
6.0
6.6
mg/l
11.9
11.4
0.22
25
185
(3045414) Leukocytes [Presence] in Urine
162
1494
1.09
0.47
1.5
1.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1573
15421
1.03
0.47
5.4
5.4
%
56.7
56.6
0.15
1476
14517
(3006653) Thiamine [Moles/volume] in Blood
11
154
0.71
0.47
1.2
1.6
nmol/l
123.9
125.7
0.05
11
154
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
67
589
1.14
0.46
1.3
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
145
1333
1.09
0.46
1.9
2.0
ug/l
10.4
5.0
0.52
133
1156
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
14
103
1.36
0.45
1.1
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
53
459
1.16
0.45
2.9
3.7
u/ml
0.4
0.4
0.30
29
256
(3052851) Hemolysis interference index of Serum or Plasma
72
811
0.89
0.45
2.6
2.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
780
7562
1.04
0.43
3.4
3.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
25
307
0.81
0.43
12.4
2.3
%
64.6
61.9
0.27
25
307
(3044927) Protein electrophoresis panel - Urine
10
140
0.71
0.43
1.1
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
11
78
1.41
0.43
1.4
2.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
96
1059
0.90
0.42
2.1
2.0
%
92.7
94.7
0.33
86
958
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
22
273
0.80
0.42
1.1
1.1
u/l
1.0
1.0
—
10
112
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
57
1.40
0.42
1.1
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
970
9450
1.04
0.42
1.3
1.3
u/ml
1.6
1.6
0.08
315
2789
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
0
15
0.00
0.41
0.0
1.1
—
11.5
—
0
15
(3017166) Chili Pepper IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
0.1
—
0
11
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
16
0.00
0.41
0.0
8.5
—
78.6
—
0
11
(3014051) Protein [Presence] in Urine by Test strip
68
763
0.89
0.41
1.9
1.9
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
300
2848
1.06
0.41
1.8
1.8
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
14
105
1.33
0.41
1.1
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
72
643
1.12
0.40
2.1
2.2
ug/l
1090.6
337.2
0.52
63
564
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
258
2439
1.06
0.40
1.1
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
32
268
1.20
0.40
1.2
1.2
—
—
—
0
0
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.0
—
0.2
—
0
12
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
25
304
0.82
0.40
1.1
1.1
—
58.0
—
0
6
(3037756) Immunofixation for Serum or Plasma
24
293
0.82
0.40
1.6
1.7
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
10
138
0.72
0.40
1.8
1.6
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
18
0.00
0.40
0.0
1.4
—
4.9
—
0
9
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.7
—
29.7
—
0
18
(3003843) Paprika IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
0.0
—
0
11
(44806071)
8
61
1.31
0.39
1.0
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3108
30857
1.04
0.39
3.3
3.4
mmol/l
4.8
4.8
0.09
2933
29324
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
112
1027
1.09
0.39
1.2
1.3
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
84
927
0.90
0.39
1.7
1.6
mmol/l
7.8
7.5
0.46
56
563
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
17
133
1.28
0.38
1.2
1.2
pmol/l
23.4
15.8
1.32
17
120
(3024471) HLA-A [Type]
9
66
1.36
0.38
1.0
1.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
90
818
1.10
0.38
1.3
1.3
titre
938.0
1067.8
—
5
41
(3047189) Immunofixation for 24 hour Urine
9
67
1.34
0.38
1.3
1.7
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
8
112
0.71
0.37
2.5
2.7
—
—
—
0
0
(3024263) Appearance of Synovial fluid
8
112
0.71
0.37
2.6
2.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
113
0.71
0.37
1.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
37
1.35
0.37
1.4
1.1
—
—
—
0
0
(4015189)
5
37
1.35
0.37
1.8
3.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3135
31141
1.04
0.37
3.5
3.6
mmol/l
2.9
2.9
0.57
2934
29399
(3000012) Reticulocyte production index
15
116
1.29
0.37
1.1
1.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
30
253
1.19
0.36
1.1
1.1
miu/ml
1681.9
1543.7
0.21
30
253
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
59
526
1.12
0.36
1.1
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
117
1264
0.92
0.35
1.1
1.1
u/ml
2.0
4.9
1.64
17
208
(3032057) Clostridioides difficile [Presence] in Stool
6
42
1.43
0.35
1.8
1.9
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
306
2923
1.05
0.35
3.4
3.4
pmol/l
4.6
4.5
0.68
269
2626
(3027456) Digoxin [Moles/volume] in Serum or Plasma
25
208
1.20
0.35
3.4
3.4
nmol/l
0.8
0.8
0.28
19
165
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
17
135
1.26
0.35
1.2
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
35
301
1.16
0.35
1.6
1.9
mg/l
18.2
27.0
—
10
84
(3036048) Francisella tularensis Ab [Titer] in Serum
10
73
1.37
0.34
1.1
1.1
—
222.9
—
0
7
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
320
3064
1.05
0.34
1.5
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
584
5664
1.04
0.34
1.4
1.5
nmol/l
21.2
21.4
0.12
503
5020
(3018677) aPTT in Platelet poor plasma by Coagulation assay
363
3487
1.05
0.33
2.0
2.0
s
28.7
29.1
0.80
348
3362
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
6
45
1.33
0.33
1.0
1.4
%
50.8
61.5
—
6
39
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1388
13647
1.03
0.33
2.3
2.2
nmol/l
75.3
74.5
0.59
1276
12742
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
87
797
1.09
0.33
1.2
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
775
7558
1.03
0.33
1.7
1.7
mg/l
1.1
0.9
0.42
577
5554
(4133840)
6
88
0.68
0.33
1.2
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
142
1329
1.07
0.33
2.3
2.7
ng/l
163.4
130.3
0.50
124
1175
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
21
173
1.22
0.32
1.0
1.0
—
—
—
0
0
(4027681)
35
303
1.16
0.32
1.3
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
87
798
1.09
0.32
3.5
2.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1882
19056
0.98
0.32
2.9
3.0
ug/l
73.9
63.9
1.85
1754
18074
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
12
92
1.31
0.31
2.0
1.5
ug/l
7.6
8.0
0.22
12
92
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1079
10582
1.03
0.31
1.7
1.8
pmol/l
97.0
99.2
0.75
573
5648
(3000991) Gas panel - Venous blood
164
1546
1.06
0.31
9.1
7.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
28
239
1.17
0.31
1.2
1.5
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
36
314
1.15
0.31
2.6
3.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
7
96
0.73
0.30
1.3
1.3
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
10
131
0.76
0.30
1.0
1.1
nmol/l
6.8
5.6
—
10
124
(3011412) CD3 cells [#/volume] in Blood
35
305
1.15
0.30
1.7
2.5
e9/l
1.5
1.3
0.36
21
184
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
24
283
0.85
0.30
1.5
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
353
3399
1.04
0.30
1.3
1.4
—
—
—
0
0
(3036489) Thrombin time
115
1233
0.93
0.30
1.6
1.9
s
20.8
20.6
0.19
89
1021
(3003458) Phosphate [Moles/volume] in Serum or Plasma
285
2731
1.05
0.30
6.1
4.6
mmol/l
1.1
1.0
0.30
263
2543
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
13
102
1.28
0.30
1.2
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
170
1608
1.06
0.29
1.2
1.3
u/l
9.0
10.6
1.06
146
1345
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
56
1.25
0.29
1.1
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
333
3207
1.04
0.29
1.8
2.1
nmol/l
395.6
379.1
0.77
311
2949
(43055514) Macroprolactin [Presence] in Serum or Plasma
17
206
0.82
0.29
1.5
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
42
373
1.13
0.29
1.2
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
43
482
0.89
0.29
1.2
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
43
482
0.89
0.29
1.2
1.2
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
8
111
0.72
0.28
2.1
2.2
nmol/l
166.1
159.7
—
8
95
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
29
334
0.87
0.28
1.3
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
20
167
1.20
0.28
1.1
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
29
251
1.16
0.28
1.4
2.1
%
10.9
12.6
0.39
11
138
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
11
140
0.79
0.28
2.5
2.4
umol/l
44.2
49.9
0.28
11
120
(21491868) Cryoglobulin [Mass/volume] in Serum
10
129
0.77
0.28
1.0
1.1
g/l
—
0.1
—
0
5
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
11
85
1.29
0.28
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
11
85
1.29
0.28
1.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
11
85
1.29
0.28
1.0
1.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
678
6622
1.03
0.27
2.4
2.1
umol/l
4987.8
3099.0
0.56
595
5869
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
172
0.81
0.27
1.2
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
243
2329
1.05
0.27
1.3
1.5
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
65
1.23
0.27
1.0
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
8
65
1.23
0.27
1.3
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
31
271
1.15
0.27
1.3
1.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
63
688
0.91
0.27
1.1
1.1
u/ml
1.2
3.2
3.57
37
381
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
15
122
1.23
0.27
1.3
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
552
5665
0.97
0.26
3.2
3.3
mg/l
617.6
452.7
0.28
357
3471
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
11
86
1.28
0.26
2.5
3.5
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
71
0.70
0.26
1.2
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
85
914
0.93
0.26
1.2
1.3
u/ml
77.1
44.4
—
10
85
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
173
1817
0.95
0.26
1.5
1.7
mg/l
3.3
3.8
0.42
112
1238
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
19
160
1.19
0.25
1.2
1.2
—
—
—
0
0
(4034850)
101
946
1.07
0.25
7.3
7.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
13
105
1.24
0.24
1.2
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
98
918
1.07
0.24
1.4
1.6
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
44
486
0.90
0.24
2.1
2.1
g/l
0.0
0.0
0.00
39
455
(3027135) IgG subclass 1 [Mass/volume] in Serum
30
339
0.88
0.24
1.5
1.4
g/l
7.5
6.4
0.42
21
235
(3011897) Casein IgE Ab [Units/volume] in Serum
6
84
0.71
0.24
1.0
1.1
—
4.1
—
0
17
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
36
322
1.12
0.23
1.4
2.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
413
4016
1.03
0.23
2.6
2.4
e6/l
5.7
5.0
0.48
226
2006
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
361
3720
0.97
0.23
1.4
1.5
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
118
1115
1.06
0.23
7.9
7.7
%
91.9
94.3
1.57
118
1108
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
67
620
1.08
0.23
3.0
3.5
u/ml
36.2
29.7
0.22
62
597
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
17
143
1.19
0.23
1.5
1.7
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
30
338
0.89
0.23
1.5
1.4
g/l
0.4
0.4
0.15
21
231
(3028192) IgG subclass 2 [Mass/volume] in Serum
30
338
0.89
0.23
1.5
1.4
g/l
2.6
2.9
0.73
21
231
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
13
106
1.23
0.23
1.0
1.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3085
30704
1.02
0.23
3.2
3.4
mmol/l
1.6
1.6
0.01
2904
29122
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
39
1.28
0.23
1.2
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
16
134
1.19
0.22
1.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
34
379
0.90
0.22
1.3
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
470
4585
1.03
0.22
2.9
2.6
ng/l
1035.9
768.7
0.86
390
3699
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
31
276
1.12
0.22
1.2
1.5
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
15
178
0.84
0.22
1.1
1.2
g/l
0.3
0.3
—
10
143
(3021387) Prolactin [Units/volume] in Serum or Plasma
267
2761
0.96
0.21
1.6
1.6
mu/l
311.2
302.8
0.10
237
2447
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
167
0.84
0.21
1.2
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
42
1.19
0.21
1.0
1.2
ng/l
102.4
86.7
—
5
42
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
0
11
0.00
0.21
0.0
1.5
—
52.4
—
0
5
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3020934) Sesame Seed IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
0.3
—
0
6
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
10.1
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
164.9
—
0
11
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
16
188
0.85
0.21
1.1
1.2
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
54
498
1.09
0.21
6.1
4.9
iu/ml
873.6
584.1
—
9
52
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
158
1512
1.05
0.21
1.4
1.5
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
44
481
0.91
0.21
2.1
2.1
g/l
0.0
0.0
0.00
39
453
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
25.7
—
0
13
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.1
—
108.7
—
0
13
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
39
354
1.10
0.20
1.4
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
17
145
1.17
0.20
1.3
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
80
1.25
0.20
1.0
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
80
1.25
0.20
1.0
1.5
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
234
2261
1.04
0.20
1.4
1.3
miu/ml
228.1
239.8
0.22
126
1177
(3044007) Cell count panel - Peritoneal fluid
6
49
1.22
0.20
2.0
1.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1069
10547
1.02
0.20
3.2
2.9
u/l
28.0
28.4
0.13
1014
10072
(36660697) Celiac disease serology panel - Serum
324
3332
0.97
0.20
1.1
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
50
1.20
0.19
1.8
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
96
1014
0.95
0.19
1.3
1.3
—
—
—
0
0
(4211845)
22
193
1.14
0.19
2.7
2.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
11
133
0.83
0.19
1.0
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
32
354
0.90
0.19
1.2
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
55
592
0.93
0.19
3.0
3.4
mg/l
35.9
21.9
0.82
24
363
(3001686) Cold agglutinin [Titer] in Serum or Plasma
6
52
1.15
0.19
1.0
1.3
—
20.0
—
0
5
(3010726) Horse dander IgE Ab [Units/volume] in Serum
96
910
1.06
0.18
1.1
1.1
u/ml
1.7
1.4
0.15
16
226
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
28
251
1.12
0.18
1.1
1.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
38
347
1.10
0.18
1.0
1.1
u/ml
0.4
2.0
—
9
100
(3020491) Glucose [Moles/volume] in Blood
31
280
1.11
0.18
1.5
1.6
mmol/l
5.5
5.9
0.28
24
226
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
36
394
0.91
0.18
1.3
1.3
—
36.1
—
0
8
(3008116) Ketones [Moles/volume] in Urine by Test strip
7
58
1.21
0.18
1.3
1.7
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
609
1.07
0.18
2.4
2.1
g/l
10.0
10.1
0.05
53
532
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
24
269
0.89
0.18
1.6
1.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
23
204
1.13
0.18
1.3
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
13
153
0.85
0.18
2.6
2.2
%
11.3
10.8
0.17
13
153
(40768797) Stomach Pathology biopsy report
392
4011
0.97
0.18
1.2
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
80
756
1.06
0.17
1.3
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
156
1501
1.04
0.17
2.3
2.3
g/l
66.7
67.2
0.46
142
1387
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
114
1089
1.05
0.17
1.1
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
55
513
1.07
0.17
1.5
1.8
e6/l
6715.0
9303.7
0.50
43
380
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
16
184
0.87
0.17
1.8
1.6
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
7
63
1.11
0.17
1.1
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
69
650
1.06
0.17
1.0
1.1
u/ml
0.0
0.1
—
8
133
(3022689) Creatine [Moles/volume] in Urine
5
67
0.75
0.17
1.2
1.5
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
79
748
1.06
0.16
1.1
1.1
u/ml
3.8
4.4
0.16
25
306
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
26
234
1.11
0.16
1.2
1.2
u/l
56.4
61.7
0.23
19
152
(3042517) Benzodiazepines panel - Urine
8
68
1.18
0.16
2.6
2.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
292
1.10
0.16
1.3
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
20
177
1.13
0.16
2.7
2.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
794
7831
1.02
0.16
1.4
1.4
g/l
2.2
2.1
0.57
509
4995
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
393
3848
1.02
0.16
1.2
1.2
iu/ml
166.1
160.9
0.08
150
1518
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
42
389
1.08
0.16
1.1
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
11
92
1.20
0.16
2.0
2.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
220
2265
0.97
0.16
8.0
14.4
inr
1.2
1.1
0.32
47
375
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
342
3498
0.98
0.16
1.4
1.4
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
13
111
1.17
0.15
1.0
1.2
%
102.8
107.4
0.28
13
106
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
13
111
1.17
0.15
1.0
1.1
%
—
5.0
—
0
15
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
15
172
0.87
0.15
1.2
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
62
584
1.06
0.15
1.1
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
413
4212
0.98
0.15
2.7
2.9
ng/l
105.4
344.4
2.56
196
2235
(3022145) Colonoscopy Study observation
324
3168
1.02
0.15
1.4
1.3
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
9
80
1.13
0.15
1.1
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
41
441
0.93
0.15
3.8
4.3
u/ml
173.9
80.9
0.25
16
131
(3000492) Spirometry study
320
3129
1.02
0.15
1.3
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
415
4071
1.02
0.15
1.5
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
236
2423
0.97
0.15
1.4
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
82
1.10
0.15
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
82
1.10
0.15
1.1
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
82
1.10
0.15
1.1
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
129
1243
1.04
0.14
1.1
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
68
717
0.95
0.14
1.2
1.2
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
7
90
0.78
0.14
1.0
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
22
198
1.11
0.14
1.2
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
22
198
1.11
0.14
1.2
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
22
198
1.11
0.14
1.2
1.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
70
665
1.05
0.14
2.3
2.1
g/l
3.4
3.7
1.33
48
490
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
70
665
1.05
0.14
2.3
2.1
g/l
7.3
7.4
0.12
51
519
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
70
665
1.05
0.14
2.3
2.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
45
421
1.07
0.14
1.4
1.7
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
23
208
1.11
0.14
1.0
1.1
%
82.8
89.0
0.43
16
166
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
169
1640
1.03
0.13
1.1
1.3
ug/l
4.8
3.4
0.34
160
1539
(3016018) Differential panel - Cerebral spinal fluid
40
373
1.07
0.13
1.3
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
64
674
0.95
0.13
1.2
1.3
nmol/l
1.3
1.4
0.33
51
558
(3020682) Albumin/Creatinine [Ratio] in Urine
598
5897
1.02
0.13
3.9
4.0
mg/mmol
9.5
11.1
0.37
374
3722
(4198724)
25
228
1.10
0.13
1.5
2.9
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
9
107
0.84
0.13
1.1
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
28
304
0.92
0.13
1.2
1.2
u/ml
0.1
0.5
—
9
96
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
343
3495
0.98
0.12
1.3
1.4
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
21
190
1.11
0.12
1.5
1.6
nmol/l
1.6
1.5
0.34
21
169
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
80
766
1.05
0.12
1.2
1.4
e6/l
83.2
5785.4
0.64
66
624
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
22
200
1.10
0.12
2.0
2.8
e6/l
771.0
838.1
0.18
11
84
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
36
336
1.07
0.12
1.6
1.4
pmol/l
353.4
353.5
0.00
28
265
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
341
3472
0.98
0.12
1.3
1.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
80
767
1.04
0.12
1.2
1.3
e6/l
159.0
18.5
0.46
64
591
(3045683) HLA typing for celiac disease panel - Blood or Tissue
29
313
0.93
0.12
1.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
238
2433
0.98
0.12
1.2
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
30
278
1.08
0.12
1.2
1.5
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
55
522
1.05
0.12
1.9
2.1
g/l
0.0
0.0
0.65
50
489
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
16
178
0.90
0.11
1.3
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
117
1207
0.97
0.11
2.4
2.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
167
1712
0.97
0.10
3.3
3.2
ng/l
82.0
74.4
0.45
151
1510
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
157
1530
1.03
0.10
1.4
1.4
—
—
—
0
0
(4094501)
51
536
0.95
0.10
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
22
202
1.09
0.10
1.1
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
13
146
0.89
0.10
3.4
3.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
209
2134
0.98
0.10
2.9
2.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
75
722
1.04
0.10
1.3
1.4
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
47
494
0.95
0.10
1.2
1.3
—
54.6
—
0
31
(3028717) Thiamine [Mass/volume] in Blood
5
44
1.14
0.10
1.8
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
37
349
1.06
0.10
1.3
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
343
3482
0.98
0.10
1.3
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
15
135
1.11
0.09
1.1
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
15
135
1.11
0.09
2.0
1.5
u/l
16.7
5.3
—
9
70
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
26
242
1.07
0.09
1.2
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
168
1643
1.02
0.09
1.9
2.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
116
1.12
0.09
1.2
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
13
116
1.12
0.09
1.4
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
66
635
1.04
0.09
2.3
2.1
g/l
3.0
3.1
0.27
51
504
(3014765) Yersinia sp identified in Stool by Organism specific culture
101
1040
0.97
0.09
1.2
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
598
5920
1.01
0.09
1.4
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
29
272
1.07
0.09
1.4
1.6
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
11
97
1.13
0.09
1.0
1.8
u/l
10.1
12.0
0.96
11
92
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
57
1.05
0.08
5.2
7.7
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
130
1269
1.03
0.08
2.1
2.1
u/l
39.0
39.1
0.02
125
1179
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
23
214
1.08
0.08
1.3
1.5
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
61
0.82
0.08
1.0
1.2
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
5
60
0.83
0.08
1.0
1.3
pmol/l
280.2
342.2
—
5
41
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
60
0.83
0.08
1.0
1.4
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
5
62
0.81
0.08
1.0
1.1
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
39
371
1.05
0.08
1.1
1.1
mg/l
193.7
207.7
0.36
31
326
(3030313) Adrenal Ab [Titer] in Serum
5
65
0.77
0.08
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
102
1047
0.97
0.08
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
28
297
0.94
0.08
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
28
297
0.94
0.08
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
28
297
0.94
0.08
1.3
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
41
429
0.96
0.07
1.5
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
8
74
1.08
0.07
1.6
1.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
24
225
1.07
0.07
1.1
1.1
—
—
—
0
0
(4062490)
32
337
0.95
0.07
1.5
1.4
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
10
112
0.89
0.07
1.0
1.1
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
7
82
0.85
0.07
1.0
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
77
748
1.03
0.07
1.3
1.2
—
5.6
—
0
10
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
237
2336
1.02
0.07
1.2
1.3
au/ml
34.7
32.9
—
5
93
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
19
204
0.93
0.07
2.1
2.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
126
1234
1.02
0.07
2.9
2.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
9
88
1.02
0.07
1.7
2.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
24
226
1.06
0.06
5.5
7.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
71
690
1.03
0.06
1.1
1.1
au/ml
9.4
11.1
—
8
46
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
34
325
1.05
0.06
1.6
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
59
572
1.03
0.06
2.8
2.2
g/l
0.4
0.5
0.21
50
514
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
22
207
1.06
0.06
1.1
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
13
119
1.09
0.06
1.4
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
28
294
0.95
0.06
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
28
294
0.95
0.06
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
28
294
0.95
0.06
1.3
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
38
365
1.04
0.06
1.3
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
41
395
1.04
0.05
1.1
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
10
90
1.11
0.05
2.0
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
40
415
0.96
0.05
1.6
1.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
691
6950
0.99
0.05
3.3
3.1
%
97.0
98.1
0.57
668
6719
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
26
273
0.95
0.05
1.1
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
287
2899
0.99
0.05
1.3
1.3
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
115
1130
1.02
0.05
1.2
1.3
u/ml
57.0
39.3
—
8
81
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
17
159
1.07
0.05
1.7
2.5
%
55.2
46.8
—
6
59
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
106
1079
0.98
0.05
1.1
1.1
u/ml
1.0
1.3
0.15
39
406
(3000060) B lymphocytes [#/volume] in Blood
11
120
0.92
0.05
1.3
1.9
e6/l
221.7
154.2
—
6
65
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
127
1290
0.98
0.05
1.3
1.5
nmol/l
0.5
0.5
0.02
98
1075
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
78
764
1.02
0.04
1.2
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
40
387
1.03
0.04
1.1
1.1
mg/l
36.5
34.7
0.12
28
324
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
28
292
0.96
0.04
1.9
1.8
u/ml
5.1
21.7
0.53
22
235
(3034274) Bile acid [Moles/volume] in Serum --fasting
137
1352
1.01
0.04
2.1
2.2
umol/l
4.4
4.9
0.50
98
993
(3001964) Herpes simplex virus Ag [Presence] in Specimen
10
109
0.92
0.04
1.3
1.3
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
28
269
1.04
0.04
1.0
1.1
iu/ml
8.2
9.0
—
6
74
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
41
398
1.03
0.04
1.2
1.2
nmol/l
—
0.5
—
0
12
(3051611) Lipemic interference index of Serum or Plasma
23
240
0.96
0.03
2.9
2.9
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
102
1034
0.99
0.03
1.2
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
114
1154
0.99
0.03
2.2
2.0
g/l
0.2
0.2
0.35
106
1091
(3008401) Mugwort IgE Ab [Units/volume] in Serum
92
907
1.01
0.03
1.0
1.1
u/ml
2.5
0.9
0.51
29
375
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
94
927
1.01
0.03
7.4
3.5
mmol/l
23.9
24.2
0.38
79
814
(3023419) Bacteria identified in Sputum by Culture
23
221
1.04
0.03
2.1
2.7
—
—
—
0
0
(3012565) Volume of 24 hour Urine
14
132
1.06
0.02
1.5
2.1
ml
1735.7
1931.2
0.37
14
121
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
100
1012
0.99
0.02
1.2
1.3
u/ml
11.5
6.0
0.34
12
102
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
55
540
1.02
0.02
1.3
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
35
359
0.97
0.02
1.2
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
38
371
1.02
0.02
1.2
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
22
212
1.04
0.02
2.1
2.8
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
77
760
1.01
0.02
1.5
1.5
mmol/l
7.7
6.8
0.91
61
535
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
138
1369
1.01
0.02
1.5
1.5
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
10
107
0.93
0.02
2.7
2.2
umol/l
14.4
15.7
—
10
107
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
10
107
0.93
0.02
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
645
6434
1.00
0.02
1.4
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
123
1.06
0.01
1.1
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
280
2789
1.00
0.01
1.6
1.8
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
21
203
1.03
0.01
2.4
2.8
—
19.7
—
0
6
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
253
2520
1.00
0.01
2.2
2.3
au/ml
21.1
21.9
0.05
18
197
(3003888) Timothy IgE Ab [Units/volume] in Serum
97
962
1.01
0.01
1.1
1.1
u/ml
7.9
5.5
0.40
40
504
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
55
543
1.01
0.01
1.3
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
11
116
0.95
0.00
1.4
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
11
116
0.95
0.00
1.1
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
12
126
0.95
0.00
1.1
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
12
126
0.95
0.00
1.1
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
126
0.95
0.00
1.1
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
12
126
0.95
0.00
1.1
1.6
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
36
354
1.02
0.00
1.0
1.0
u/ml
1.9
0.8
—
7
77
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
37
364
1.02
0.00
1.1
1.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
169
1696
1.00
0.00
7.3
5.6
mmol/l
1.4
1.3
0.64
164
1632
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
10
98
1.02
0.00
1.1
1.3
u/l
176.4
351.9
—
10
93
(40768806) Pleura Pathology biopsy report
12
118
1.02
0.00
1.4
1.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
10
105
0.95
0.00
1.0
1.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
11
115
0.96
0.00
1.0
1.1
iu/ml
—
4.3
—
0
10
(44790048)
28
278
1.01
0.00
1.3
1.4
—
—
—
0
0
(44790049)
28
278
1.01
0.00
1.3
1.4
—
—
—
0
0
(44790047)
28
278
1.01
0.00
1.3
1.4
—
—
—
0
0
(44806118)
28
278
1.01
0.00
1.3
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
31
312
0.99
0.00
1.2
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
19
195
0.97
0.00
1.7
2.0
u/field
2.6
2.1
—
8
100
(3000570) Elastase.pancreatic [Mass/mass] in Stool
73
728
1.00
0.00
1.2
1.3
ug/g
349.8
314.0
0.59
41
354
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
10
99
1.01
0.00
1.1
1.0
u/ml
0.1
1.7
—
5
67
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
16
159
1.01
0.00
1.3
1.6
u/field
1.1
3.3
—
8
114
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
19
191
0.99
0.00
1.2
1.2
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
24
239
1.00
0.00
1.1
1.0
mg/l
319.3
298.6
0.80
24
216
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
103
1026
1.00
0.00
1.3
1.3
u/ml
12.3
10.5
0.08
15
173
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
32
319
1.00
0.00
1.4
1.6
mmol/l
5.5
5.1
1.37
32
305
(3003327) Ova and parasites identified in Stool by Light microscopy
149
1486
1.00
0.00
1.7
1.7
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
48
479
1.00
0.00
4.3
2.6
nmol/l
0.9
0.9
0.19
41
408
(3037121) Protein [Mass/volume] in Urine
85
851
1.00
0.00
3.1
2.8
g/l
0.4
0.3
0.10
29
318
(3003740) Influenza virus B Ag [Presence] in Specimen
83
831
1.00
0.00
1.1
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
56
556
1.01
0.00
1.1
1.2
iu/ml
58.4
17410.0
0.64
21
154
(3012441) Differential panel - Pleural fluid
12
116
1.03
0.00
1.2
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
41
407
1.01
0.00
1.3
1.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
10
103
0.97
0.00
1.1
1.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
10
103
0.97
0.00
1.1
1.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
83
833
1.00
0.00
1.1
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
81
807
1.00
0.00
1.0
1.1
u/ml
6.2
4.6
0.18
26
309
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
10
103
0.97
0.00
1.1
1.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
22
223
0.99
0.00
2.3
2.1
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
51
0.98
0.00
1.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
6
61
0.98
0.00
1.0
1.2
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3013862) HLA-DP [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
1528.0
—
0
5
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
77
0.91
0.00
1.1
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
91
0.99
0.00
1.4
1.3
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
6
64
0.94
0.00
1.0
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
119
1190
1.00
0.00
2.1
2.0
g/l
1.1
1.2
0.74
110
1127
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
0
7
0.00
0.00
0.0
1.1
—
167.6
—
0
7
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
5.1
—
0.2
—
0
9
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
2.9
—
0
7
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.1
—
0
5
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
75
0.93
0.00
1.7
3.3
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
17
170
1.00
0.00
1.2
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
56
560
1.00
0.00
1.4
1.5
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.5
—
2.6
—
0
8
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000219) Insulin receptor Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
6
59
1.02
0.00
1.3
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
54
0.93
0.00
1.2
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
91
0.99
0.00
1.4
1.3
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
9
89
1.01
0.00
5.3
2.6
—
—
—
0
0
(4146454)
16
160
1.00
0.00
2.3
2.8
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
52
520
1.00
0.00
2.0
2.1
g/l
38.0
38.5
0.19
44
468
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
82
0.98
0.00
1.1
1.1
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.6
—
574.6
—
0
5
(3010937) Rubella virus Ab [Presence] in Serum
5
56
0.89
0.00
1.4
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_CERVIX_UTERI – Carcinoma in situ of cervix uteri

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).